Pharmaceutical Drugs Global Market Report 2024

Description

A pharmaceutical drug is a substance designed for the treatment, prevention, or alleviation of an illness, condition, or its symptoms. These substances can be administered through various methods, including oral consumption, skin patches, injections, or inhalation. Notable pharmaceuticals derived from natural sources encompass vaccinations, steroid hormones, human blood-plasma fractions, and antibiotics.

The primary categories of pharmaceutical drugs cover a wide spectrum, including cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorders drugs, musculoskeletal disorders drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, and respiratory diseases drugs. Cardiovascular drugs are specifically tailored to address medical conditions related to the heart or circulatory system, such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke. These drugs can be administered through various routes, including oral and parenteral methods, and are categorized as branded or generic drugs. The acquisition of pharmaceutical drugs can occur through prescription-based or over-the-counter channels, with distribution taking place through hospital pharmacies, retail pharmacies/drug stores, and other outlets.

The pharmaceutical drug market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical drug market statistics, including pharmaceutical drug industry global market size, regional shares, competitors with a pharmaceutical drug market share, detailed pharmaceutical drug market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug industry. This pharmaceutical drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical drugs market size has grown strongly in recent years. It will grow from $1199.86 billion in 2023 to $1267.05 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The expansion in the historical period can be ascribed to an upswing in healthcare awareness, a heightened prevalence of respiratory diseases, shifts in lifestyles, a surge in pharmaceutical research and development (R&D) expenditure, a growing aging population, a rise in the number of surgical procedures, robust economic growth in emerging markets, and an increased number of approvals for hematology/oncology (cancer) drugs.

The pharmaceutical drugs market size is expected to see rapid growth in the next few years. It will grow to $2092.95 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The expansion in the forecast period can be attributed to growing government support, an increase in healthcare access, a rise in investments, rapid growth in the elderly population, an upsurge in healthcare expenditure, and heightened awareness of immunization and vaccination. Key trends in the forecast period include the use of biomarkers for drug development, an increased focus on next-generation biologics development, a heightened emphasis on personalized medicine, investments in artificial intelligence (AI) for drug discovery, the adoption of combination drug therapy for respiratory diseases, partnerships with wearables companies to enhance drug research and development, the utilization of 3D printing technology in drug manufacturing, the development of microneedle pills for improved drug delivery, and advancements in vaccine development using mRNA technology.

The increase in sedentary jobs, busy lifestyles, and evolving consumer preferences is impacting the global disease landscape, particularly the prevalence of non-communicable diseases such as cancer, diabetes, and cardiovascular conditions. Factors such as prolonged working hours, reduced physical activity, and unhealthy dietary habits contribute significantly to chronic diseases such as diabetes. According to the World Health Organization, noncommunicable diseases (NCDs) account for 41 million deaths annually, representing 74% of global mortality. This trend underscores the growing demand for biologic drugs to address conditions such as diabetes. These factors are anticipated to expand the global patient population, thereby fostering growth in the pharmaceutical drug market throughout the forecast period.

The escalating occurrence of rare diseases is expected to drive the pharmaceutical drug market in the future. Rare diseases, characterized by low prevalence in comparison to more common health issues, affect only a small percentage of the population. Pharmaceutical drugs play a crucial role in managing these diseases, facilitating the identification of potential therapeutics, and preventing unnecessary treatments with severe side effects, contributing to effective treatment approaches. For instance, as of February 2021, the International Osteoporosis Foundation (IOF) reported that over 300 million people worldwide are affected by rare diseases, constituting 3.5% to 5.9% of the global population. Additionally, in November 2022, Health Match, an Australia-based digital health company, highlighted approximately 150 rare kidney diseases with high prevalence rates, ranging from 60 to 80 incidences per 100,000 people in America and Europe. Hence, the increasing incidence of rare diseases acts as a catalyst for the pharmaceutical drug market's growth.

Leading companies in the pharmaceutical drug market are introducing innovative medications such as Sohonos (palovarotene) capsules to establish a competitive advantage. Sohonos, a retinoid, is designed to reduce the volume of new heterotopic ossification in individuals with fibrodysplasia ossificans progressiva (FOP). For instance, in August 2023, Ipsen Biopharmaceuticals, Inc., a France-based biopharmaceutical company, unveiled Sohonos (palovarotene). This retinoid is indicated for minimizing the volume of new heterotopic ossification in adults and pediatric patients (8 years and older for females, 10 years and older for males) with FOP-a rare genetic disorder characterized by abnormal bone development in areas not typically containing bone, leading to limited movement, deformities, and severe disability.

An emerging trend in the dermatology drugs market is the early Rx-to-OTC switch, where products transition from prescription to non-prescription status. Traditionally, this shift occurred near the drug's patent expiry or afterward. However, forward-thinking companies are now opting for early Rx-to-OTC switches well in advance of patent expiry to capitalize on market opportunities and recover product-related expenses. This strategy offers additional benefits to manufacturers. For instance, in 2020, the FDA approved the switch of three prescription drugs to OTC status, including Voltaren for arthritis pain and olopatadine hydrochloride 0.1% and 0.2% (Pataday Twice Daily Relief and Pataday Once Daily Relief) for temporary relief of itchy and red eyes caused by pollen, ragweed, and grass.

Major companies operating in the pharmaceutical drugs market report are Pfizer Inc., AbbVie, Johnson & Johnson, Merck & Co, Sanofi S.A., F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb, AstraZeneca, GlaxosmithKline, Shanghai Pharmaceutical Drugs, Shanghai Fosun Pharmaceutical, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd. (Sinopharm), Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd., Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharma, KYORIN Holdings, Inc., Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd., Kalbe Farma, Hyphens Pharma, Adjuvanz Technology Pte Ltd., Alliance Pharm Pte Ltd., Teva UK Limited, Abbott Laboratories, Vectura Group, Boehringer Ingelheim, Mylan, Zentiva, Apotex, Gilead Sciences, Bayer, Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, Eli Lilly & Company, Biogen, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Uniao Quimica, Ache, Mantecorp Farmasa, Libbs, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Julphar, Neopharma, Johnson & Johnson, Eurolab, Aspen.

North America was the largest region in the pharmaceutical drugs market in 2023. Middle East is expected to be the fasted growing region in the forecast period. The regions covered in the pharmaceutical drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical drugs market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The pharmaceutical drug market consists of sales of generic drugs, over-the-counter medications, bulk drugs, vaccines, biosimilars, and biologics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1)By Type: Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorder Drugs; Musculoskeletal Disorder Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Disease Drugs; Vaccine And Therapeutic Nutrients; Minerals
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Other Distribution Channels
3) By Drug Classification: Branded Drugs; Generic Drugs
4) By Mode Of Purchase: Over-The-Counter (OTC) Drugs; Prescription-Based Drugs
Sub segments: Anti-Hypertensive Drugs; Hypolipidemic; Anti-Thrombotic; Angina Pectoris; Congestive Heart Failure; Other Drugs For Cardiovascular Diseases (Anti-Arrhythmic And Anti-Anginal Drugs); Acne; Dermatitis; Psoriasis; Other Drugs For Dermatology Diseases; Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrheals; Hormonal Contraceptives; Drugs For Benign Prostatic Hyperplasia; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence; Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics; Blood Products And Anemia; Other Blood Disorder Drugs; Antibiotics; Antivirals; Antifungals; Others (Anthelminthic, Antiprotozoal); Anti-Diabetic Drugs; Anti-Thyroid Drugs; Anti-Obesity; Others; Drugs For Rheumatoid Arthritis; Muscle Relaxants; Other Musculoskeletal Disorders Drugs; Analgesics; Anti-Parkinson Drugs; Anesthetics; Anti-Epileptics; Alzheimer; Other CNS Drugs; Drugs For Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Tumor; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmology Drugs; Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations; Therapeutic Vaccines And Preventive Vaccines; Electrolytes And Minerals; Vitamins
Companies Mentioned: Pfizer Inc.; AbbVie; Johnson & Johnson; Merck & Co; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r14572

1. Executive Summary

2. Pharmaceutical Drugs Market Characteristics

3. Pharmaceutical Drugs Product/Service Analysis -Product/Service Examples

3.1. Pharmaceutical Drugs Supply Chain Analysis
- 3.1.1. Pharmaceutical Drugs Resources
- 3.1.2. Pharmaceutical Drugs Manufacturers
- 3.1.3. Pharmaceutical Drugs Distributors and Retailers
- 3.1.4. Pharmaceutical Drugs End Users
3.2. Pharmaceutical Drugs Customer Information

4. Pharmaceutical Drugs Market Trends And Strategies

5. Pharmaceutical Drugs Market - Macro Economic Scenario

5.1. Impact Of High Inflation On The Market
5.2. Ukraine-Russia War Impact On The Market
5.3. COVID-19 Impact On The Market

6. Global Pharmaceutical Drugs Market Size and Growth

6.1. Global Pharmaceutical Drugs Market Drivers and Restraints
- 6.1.1. Drivers Of The Market
- 6.1.2. Restraints Of The Market
6.2. Global Pharmaceutical Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
6.3. Global Pharmaceutical Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

7. Pharmaceutical Drugs Market Segmentation

7.1. Global Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cardiovascular Drugs
Dermatology Drugs
Gastrointestinal Drugs
Genito-Urinary Drugs
Hematology Drugs
Anti-Infective Drugs
Metabolic Disorders Drugs
Musculoskeletal Disorders Drugs
Central Nervous System Drugs
7.2. Global Pharmaceutical Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Branded Drugs
Generic Drugs
7.3. Global Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
Other Route Of Administration
7.4. Global Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Prescription-Based Drugs
Over-The-Counter Drugs
7.5. Global Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies/ Drug Stores
Other Distribution Channels

8. Pharmaceutical Drugs Market Regional And Country Analysis

8.1. Global Pharmaceutical Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.2. Global Pharmaceutical Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. Asia-Pacific Pharmaceutical Drugs Market

9.1. Asia-Pacific Pharmaceutical Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
9.2. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9.3. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9.4. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10. China Pharmaceutical Drugs Market

10.1. China Pharmaceutical Drugs Market Overview
10.2. China Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10.3. China Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10.4. China Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

11. India Pharmaceutical Drugs Market

11.1. India Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. India Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. India Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Japan Pharmaceutical Drugs Market

12.1. Japan Pharmaceutical Drugs Market Overview
12.2. Japan Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Japan Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.4. Japan Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Australia Pharmaceutical Drugs Market

13.1. Australia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Australia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Australia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. Indonesia Pharmaceutical Drugs Market

14.1. Indonesia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. Indonesia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. Indonesia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. South Korea Pharmaceutical Drugs Market

15.1. South Korea Pharmaceutical Drugs Market Overview
15.2. South Korea Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. South Korea Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. South Korea Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. Bangladesh Pharmaceutical Drugs Market

16.1. Bangladesh, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
16.2. Bangladesh, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

17. Thailand Pharmaceutical Drugs Market

17.1. Thailand, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
17.2. Thailand, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

18. Vietnam Pharmaceutical Drugs Market

18.1. Vietnam, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
18.2. Vietnam, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

19. Malaysia Pharmaceutical Drugs Market

19.1. Malaysia, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
19.2. Malaysia, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

20. Singapore Pharmaceutical Drugs Market

20.1. Singapore, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
20.2. Singapore, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

21. Philippines Pharmaceutical Drugs Market

21.1. Philippines, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
21.2. Philippines, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

22. Hong kong Pharmaceutical Drugs Market

22.1. Hong Kong, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
22.2. Hong Kong, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

23. New Zealand Pharmaceutical Drugs Market

23.1. New Zealand, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
23.2. New Zealand, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

24. Western Europe Pharmaceutical Drugs Market

24.1. Western Europe Pharmaceutical Drugs Market Overview
24.2. Western Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. Western Europe Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. Western Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. UK Pharmaceutical Drugs Market

25.1. UK Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.2. UK Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. UK Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. Germany Pharmaceutical Drugs Market

26.1. Germany Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.2. Germany Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. Germany Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. France Pharmaceutical Drugs Market

27.1. France Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. France Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. France Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Italy Pharmaceutical Drugs Market

28.1. Italy Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.2. Italy Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Italy Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Spain Pharmaceutical Drugs Market

29.1. Spain Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.2. Spain Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Spain Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Austria Pharmaceutical Drugs Market

30.1. Austria, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
30.2. Austria, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

31. Belgium Pharmaceutical Drugs Market

31.1. Belgium, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
31.2. Belgium, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

32. Denmark Pharmaceutical Drugs Market

32.1. Denmark, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
32.2. Denmark, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

33. Finland Pharmaceutical Drugs Market

33.1. Finland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
33.2. Finland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

34. Ireland Pharmaceutical Drugs Market

34.1. Ireland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
34.2. Ireland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

35. Netherlands Pharmaceutical Drugs Market

35.1. Netherlands, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
35.2. Netherlands, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

36. Norway Pharmaceutical Drugs Market

36.1. Norway, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
36.2. Norway, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

37. Portugal Pharmaceutical Drugs Market

37.1. Portugal, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
37.2. Portugal, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

38. Sweden Pharmaceutical Drugs Market

38.1. Sweden, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
38.2. Sweden, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

39. Switzerland Pharmaceutical Drugs Market

39.1. Switzerland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
39.2. Switzerland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

40. Eastern Europe Pharmaceutical Drugs Market

40.1. Eastern Europe Pharmaceutical Drugs Market Overview
40.2. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
40.3. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
40.4. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

41. Russia Pharmaceutical Drugs Market

41.1. Russia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
41.2. Russia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
41.3. Russia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

42. Czech Republic Pharmaceutical Drugs Market

42.1. Czech Republic, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
42.2. Czech Republic, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

43. Poland Pharmaceutical Drugs Market

43.1. Poland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
43.2. Poland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

44. Romania Pharmaceutical Drugs Market

44.1. Romania, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
44.2. Romania, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

45. Ukraine Pharmaceutical Drugs Market

45.1. Ukraine, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
45.2. Ukraine, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

46. North America Pharmaceutical Drugs Market

46.1. North America Pharmaceutical Drugs Market Overview
46.2. North America Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
46.3. North America Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
46.4. North America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

47. USA Pharmaceutical Drugs Market

47.1. USA Pharmaceutical Drugs Market Overview
47.2. USA Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
47.3. USA Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
47.4. USA Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

48. Canada Pharmaceutical Drugs Market

48.1. Canada Pharmaceutical Drugs Market Overview
48.2. Canada Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
48.3. Canada Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
48.4. Canada Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

49. Mexico Pharmaceutical Drugs Market

49.1. Mexico, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
49.2. Mexico, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

50. South America Pharmaceutical Drugs Market

50.1. South America Pharmaceutical Drugs Market Overview
50.2. South America Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
50.3. South America Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
50.4. South America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

51. Brazil Pharmaceutical Drugs Market

51.1. Brazil Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
51.2. Brazil Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
51.3. Brazil Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

52. Chile Pharmaceutical Drugs Market

52.1. Chile, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
52.2. Chile, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

53. Argentina Pharmaceutical Drugs Market

53.1. Argentina, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
53.2. Argentina, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

54. Colombia Pharmaceutical Drugs Market

54.1. Colombia, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
54.2. Colombia, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

55. Peru Pharmaceutical Drugs Market

55.1. Peru, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
55.2. Peru, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

56. Middle East Pharmaceutical Drugs Market

56.1. Middle East Pharmaceutical Drugs Market Overview
56.2. Middle East Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
56.3. Middle East Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
56.4. Middle East Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

57. Saudi Arabia Pharmaceutical Drugs Market

57.1. Saudi Arabia, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
57.2. Saudi Arabia, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

58. Israel Pharmaceutical Drugs Market

58.1. Israel, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
58.2. Israel, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

59. Iran Pharmaceutical Drugs Market

59.1. Iran, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
59.2. Iran, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

60. Turkey Pharmaceutical Drugs Market

60.1. Turkey, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
60.2. Turkey, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

61. United Arab Emirates Pharmaceutical Drugs Market

61.1. United Arab Emirates, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
61.2. United Arab Emirates, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

62. Africa Pharmaceutical Drugs Market

62.1. Africa Pharmaceutical Drugs Market Overview
62.2. Africa Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
62.3. Africa Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
62.4. Africa Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

63. Egypt Pharmaceutical Drugs Market

63.1. Egypt, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
63.2. Egypt, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

64. Nigeria Pharmaceutical Drugs Market

64.1. Nigeria, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
64.2. Nigeria, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

65. South Africa Pharmaceutical Drugs Market

65.1. South Africa, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
65.2. South Africa, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

66. Pharmaceutical Drugs Market Competitive Landscape And Company Profiles

66.1. Pharmaceutical Drugs Market Competitive Landscape
66.2. Pharmaceutical Drugs Market Company Profiles
- 66.2.1. Pfizer Inc.
  - 66.2.1.1. Overview
  - 66.2.1.2. Products and Services
  - 66.2.1.3. Strategy
  - 66.2.1.4. Financial Performance
- 66.2.2. AbbVie
  - 66.2.2.1. Overview
  - 66.2.2.2. Products and Services
  - 66.2.2.3. Strategy
  - 66.2.2.4. Financial Performance
- 66.2.3. Johnson & Johnson
  - 66.2.3.1. Overview
  - 66.2.3.2. Products and Services
  - 66.2.3.3. Strategy
  - 66.2.3.4. Financial Performance
- 66.2.4. Merck & Co
  - 66.2.4.1. Overview
  - 66.2.4.2. Products and Services
  - 66.2.4.3. Strategy
  - 66.2.4.4. Financial Performance
- 66.2.5. Sanofi S.A.
  - 66.2.5.1. Overview
  - 66.2.5.2. Products and Services
  - 66.2.5.3. Strategy
  - 66.2.5.4. Financial Performance

67. Pharmaceutical Drugs Market Other Major And Innovative Companies

67.1. F. Hoffmann-La Roche Ltd.
67.2. Novartis AG
67.3. Bristol-Myers Squibb
67.4. AstraZeneca
67.5. GlaxosmithKline
67.6. Shanghai Pharmaceutical Drugs
67.7. Shanghai Fosun Pharmaceutical
67.8. Takeda Pharmaceutical Company Ltd.
67.9. Otsuka Pharmaceutical Co. Ltd.
67.10. Daiichi Sankyo
67.11. China National Pharmaceutical Group Co., Ltd. (Sinopharm)
67.12. Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd.
67.13. Jiangsu Hengrui Medicine Co., Ltd
67.14. Hanmi Pharmaceutical
67.15. Cipla Limited

68. Global Pharmaceutical Drugs Market Competitive Benchmarking

69. Global Pharmaceutical Drugs Market Competitive Dashboard

70. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market

71. Pharmaceutical Drugs Market Future Outlook and Potential Analysis

71.1 Pharmaceutical Drugs Market In 2028 - Countries Offering Most New Opportunities
71.2 Pharmaceutical Drugs Market In 2028 - Segments Offering Most New Opportunities
71.3 Pharmaceutical Drugs Market In 2028 - Growth Strategies
- 71.3.1 Market Trend Based Strategies
- 71.3.2 Competitor Strategies

72. Appendix

72.1. Abbreviations
72.2. Currencies
72.3. Historic And Forecast Inflation Rates
72.4. Research Inquiries
72.5. The Business Research Company
72.6. Copyright And Disclaimer